Share

 
 

Biological Pathways

Dedicated to Rigorous and Groundbreaking Science

As a result of our commitment to basic research, Genentech, a member of the Roche Group, has a robust product pipeline, with innovative compounds designed to target cancer through specific molecular processes.

Select any of the research areas below to learn more: